Fontan相关肝病肝结节的超声造影观察者间一致性
5例活检结节中超声造影诊断与病理一致4例。
要点
- Fontan相关肝病结节以FNH样病变为主(57%),超声造影诊断一致性极高。
- 超声造影诊断与病理高度一致,仅1例疑似恶性被活检证实为良性腺瘤。
- CT/MRI显示38%结节有廓清,而超声造影仅14%出现廓清,判读时需注意。
关键影像表现/征象
- 多期腹部CT或MRI评估的29个结节中11个(38%)见廓清,而超声造影仅4个(14%)出现廓清。
诊断标准与关键数值
- 超声造影引导下结节诊断的观察者间一致性为100%(κ=1,未观察到分歧)。
- 超声造影表现观察者间一致性除动脉期肝脏增强模式(平均κ=0.92,标准误=0.07)和病灶回声(平均κ=0.55,标准误=0.13)外均为100%。
- 5例活检结节中,超声造影诊断与病理诊断一致4例,1例超声造影诊断为可能的恶性而活检证实为良性腺瘤。
临床应用与阅片要点
- 超声造影可用于Fontan相关肝病结节的诊断,观察者间一致性高,支持其作为结节评估工具。
- 判读时注意超声造影的廓清出现率低于CT/MRI,不应仅凭廓清否定良性诊断。
- 动脉期增强模式和病灶回声的一致性相对较低,报告时需描述具体表现。
局限性
- 仅5个结节获得病理诊断,诊断准确性的参考标准不完整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The Fontan procedure for single-ventricle congenital heart disease enables survival into adulthood but causes Fontan-associated liver disease (FALD), characterized by progressive hepatic fibrosis and hepatic nodules. Contrast-enhanced US (CEUS) is a proven method to evaluate hepatic nodules, but CEUS findings of FALD nodules have not been systematically described. Purpose To evaluate hepatic CEUS findings and assess interobserver agreement in CEUS interpretations in participants with FALD. Materials and Methods This single-center prospective study included participants with FALD who underwent hepatic CEUS between June 2018 and December 2023. Imaging was evaluated blindly by two CEUS-specialized physicians. Clinical variables were collected via chart review, and biopsy diagnoses were obtained from pathologic examination. Interobserver variability in CEUS findings and diagnoses was quantified using Cohen κ, reported as means and standard errors. Results This study included 32 participants (mean age, 30 years ± 8.7 [SD]; 19 male). Thirty-five hepatic nodules were evaluated, including 20 (57%) focal nodular hyperplasia-like lesions, seven (20%) regenerative nodules, five (14%) hemangiomas, and three (9%) possible malignancies. Interobserver agreement was 100% (κ = 1; no disagreements observed) for CEUS-guided nodule diagnoses. Interobserver agreement was also 100% for CEUS findings, except arterial phase hepatic enhancement pattern (mean κ = 0.92; standard error = 0.07) and lesion echogenicity (mean κ = 0.55; standard error = 0.13). For five biopsied FALD nodules, CEUS diagnosis agreed with pathologic diagnosis, except for one diagnosis of possible malignancy that was biopsy-proven benign adenoma. Washout was seen in 38% (11 of 29) of nodules evaluated with multiphase abdominal CT or MRI. However, at CEUS, only 14% (four of 29) exhibited washout. Conclusion In participants with FALD, there was excellent interobserver agreement in the evaluation of FALD nodules at hepatic CEUS, and CEUS diagnoses mostly agreed with pathologic diagnoses in the subset of cases with biopsies, including for malignant lesions and lesions requiring follow-up. © RSNA, 2026 See also the editorial by Barr in this issue.
引用
- Mittelstein DR, Khurana A, Vodkin I, et al. Interobserver Agreement in Contrast-enhanced US for Hepatic Nodules in Patients with Fontan-associated Liver Disease. Radiology. 2026. PMID: 42188731. doi:10.1148/radiol.252622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。